Company · CIK 0001812364 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Relay Therapeutics, Inc. · RLAY
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 SForm 4 → | Sep 9, 4:17 pm EDT | Donald A BergstromPresident, R&D | 8,530 | $18.97 | $161,814 | 399,130 | −2.09% | 10b5-1 |
| Sep 8, 2026 SForm 4 → | Sep 9, 4:15 pm EDT | Thomas CatinazzoChief Financial Officer | 17,717 | $18.94 | $335,560 | 122,851 | −12.6% | 10b5-1 |
| Sep 8, 2026 SForm 4 → | Sep 9, 4:12 pm EDT | Sanjiv PatelPresident and CEO, Director | 48,199 | $18.94 | $912,889 | 519,500 | −8.49% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.